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ABSTRACT
￿
An important limitation in the use of the murine erythroleukemia (MEL) cell system
as an in vitro system for the study of terminal erythroid differentiation has been the inability
to produce significant numbers of cells which represent the end-point of the pathway in vitro.
We show here that a major reason for the failure to observe end-stage cells in vitro is that such
cells are physically unstable under the standard culture conditions used for MEL cell differen-
tiation. Modification of these culture conditions by the addition of either bovine serum
albumin or Ficoll leads to physical stabilization of end-stage cells. Under such culture condi-
tions, uniform cultures of terminally differentiated MELcells with morphological characteristics
similar to those of normal mouse orthochromatophilic erythroblasts and reticulocytes are
observed . Examination of physical and biochemical parameters of these cell populations give
values which are similar to values characteristic of mouse reticulocytes. A physically stabilized
MEL cell shows a narrow cell volume distribution with an average value of -100 p,m3, similar
to the cell volume distribution observed for mouse reticulocytes, while a typical MEL cell
culture treated with DMSO but without a stabilizing agent exhibits a broader, more hetero-
geneous cell volume distribution with an average value of -500 p,m3. Globin mRNA levels and
levels of globin synthesis reach values almost equal to those in mouse reticulocytes in cultures
of physically stabilized MEL cells while differentiating cultures not treated with a stabilizing
agent reach substantially lower values for these parameters. We suggest that the ability to
produce populations of MEL cells which undergo complete terminal erythroid differentiation
in vitro will allow the analysis of the molecular mechanisms which control the terminal stages
of the erythroid differentiation process.
The in vitro differentiation exhibited by murine erythroleuke-
mia (MEL) cells has served as a valuable model system for
analyzing many important aspects of the erythroid differentia-
tion process (5, 14). A major drawback to this system has been
that in vitro differentiation does not appear to reach the final
stages of the normal erythroid differentiation pathway. A
number of possible explanations for the apparently incomplete
in vitro differentiation of MEL cells can be proposed. It is
possible that culture conditions used for the propagation of
MEL cells prevent completion of the differentiation program.
Alternatively, the genetic program expressed by MEL cells
may not reflect the complete program of normal erythroid
differentiation.
It has been reported by Ikawa et al. (9), Friedman and
Schildkraut (3), and Tsiftsoglou et al. (16) that small numbers
of reticulocytes can be observed in certain MEL cell cultures.
These observations suggest that the former explanation may
be correct and that terminal differentiation may be promoted
or stabilized by an alteration in culture conditions.
In the course of biochemical experiments on MEL cells we
observed that fully differentiated MEL cellscan be easily lysed
by washing with physiological saline or culture medium with-
out serum. This observation suggested to us that terminally
differentiated MEL cells may be particularly fragile in the
absence of serum. We reasoned that ifculture conditions could
be devised which protect the terminally differentiated cell from
lysis, then relatively pure populations of end stage erythroid
cells could be produced in the MEL cell system. The ability to
manipulate the MEL cell system so that end-stage cells can be
produced would be valuable for many types of studies.
We have found that such populations of MEL cells can
actually be obtained by addition of an appropriate amount of
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macia Fine Chemicals, Uppsala, Sweden) to the culture me-
dium of differentiating MEL cells. In this report we have
analyzed in detail the factors which are significant in obtaining
terminally differentiated erythroid cells in the MEL cell system
and present evidence which supports the view that stabilization
of fragile cells is a key factor in the production of such cell
populations.
MATERIALS AND METHODS
Cell Growth
Cell line 745 was originally obtained from Dr. C. Friend of Mount Sinai
Schoolof Medicine, NewYork.Freshlycloned cells, clone745-PC-4-7, a subclone
ofthis line, with very high probability ofcommitment as detected by plasma clot
assay (4), was used in these experiments. Cultures were maintained in medium
lacking nucleosides (a-) and supplemented with 13% vol/vol heat-inactivated
fetal calf serum (FCS; Gibco Laboratories, Grand Island Biological Co., Grand
Island, NY). Cells were grown in a humid C02 incubator (5% CO2) at 37°C.
Cells were maintained in culture for no more than 20 generations and then
replaced by frozen cells ofthe same clone. Erythroid differentiation was induced
by addition of dimethyl sulfoxide (DMSO) (MCB Manufacturing Chemicals,
Inc., Cincinnati, OH) to 1.8% to newly subcultured cells at a density of 5-10 x
10' cells/ml. Where indicated in text, BSA(Sigma Chemical Co., St. Louis, MO;
prepared as described by McLeod et al. and adjusted to pH 7.4 with HEPES-
NaOH) and iron-dextran complex were also added to the culture. In these
experiments cellswere grown in 3% BSA for 1-2 d before induction. Cellnumber
and cell volume distribution were determined with an automatic cell counter,
equipped with channelyzer (Coulter Counter, model ZBI, Coulter Electronics,
Inc., Hialeah, FL).
Labeling of Cells with [ t 4C]Thyrnidine
Cells were labeled for 6 hwith 0.5 IACi/ml [methyl-"C]thymidine (Amersham
Corp., Arlington Heights, IL; 55 Ci/mmol), then concentrated, washed, resus-
pended in fresh ámedium, and divided into three cultures. These cultures were
treated as indicated in the legend to Fig. l. To measure the incorporation of
radioactive thymidine into DNA, cells were harvestedby centrifugation and lysed
in buffer containing 50 mM HEPES, pH 8.0, 50 mM NaCl, 5 MM MgCl2, 0.25
Msucrose, and 0.5% Triton X-100. Nuclei were then separated by centrifugation
at 3,000 rpm for 10 min, lysed with 2% SDS, sonicated, and ['"C]thymidine
remaining in TCA-precipitable form was determined in a Beckman scintillation
counter (Beckman Instruments, Inc., Electronic Instruments, Schiller Park, IL).
Preparation of RNA and Hybridization with
Globin cDNA
MEL cell cytoplasmic RNA was prepared as described by Aviv et al. (1).
Mouse reticulocytes and reticulocyte RNAwere prepared from BALB/c mice by
standard techniques (15). Poly(A)-containing RNAwasprepared asdescribedby
Aviv and Leder (2). Hybridization with tritiated globin cRNA (sp act 2.8 x 10'
cpm/gg) was carried out as described by Ross et al. (15). The reaction was
.terminated by treatment with SI nuclease as described by Housman et al. (7).
Freezing of MEL Cells
1-2 x 10' MELcells were concentrated by centrifugation to a final volume of
1 ml in á medium containing 25% fetal bovine serum and 10% DMSO. The
cells were frozen at a rate of 1°C/min and stored in liquid nitrogen.
RESULTS
To directly test the hypothesis that significant cell lysis was
occurring during terminal differentiation of MEL cells in vitro,
the experiment shown in Table I was performed. Cells were
labeled with [t"C]thymidine for a period of 6 h in the absence
of inducer. These cells were carefully washed to remove unin-
corporated [t"C]thymidine (TdR), and the culture was divided
into three portions. In all cases cell density was maintained
below 2 X 106 by addition of the appropriately supplemented
culture medium. One aliquot was incubated in standard culture
medium in the absence ofinducer. Over a 7-d period the stably
incorporated ["C]TdR present in a standard sample of this
culture decreased no more than 10%. A culture treated with
DMSO under standard conditions for induction of MEL cell
differentiation showed no significant decrease in ["C]TdR up
to day three. However, between day four and day seven of
DMSO treatment, the period during which the maximum
number of highly differentiated erythroblasts are observed in
these cultures, a significant decrease in [
L"C]TdR levels per
aliquot is observed. By day 7, >60% of the incorporated ["Cl
TdR is no longer present in acid-precipitable form. These
results are consistent with the view that significant cell lysis
has occurred in the period following 3 d of DMSO treatment.
We have examined a variety of treatments designed to physi-
callystabilize end stage erythroblasts in this system. The effects
of one such treatment on the ["C]TdR levels are also shown in
Table 1. It is clear that 90% of the ["C]TdR remains TCA-
precipitable during the course of 7 d ofDMSO treatment when
3% BSA is added to the medium.
To further analyze the properties of terminally differentiat-
ing MEL cells treated with BSA, a series of experiments was
performed in which the morphological characteristics of
DMSO-treated MEL cells stabilized by BSA treatment were
monitored.
A field of cells from a culture treated with DMSO for 5 d to
which neither BSA nor Ficoll has been added is shown in Fig.
1 A. This field is typical of preparations made from such
cultures in the sense that although almost all the cells are
benzidine positive and hencecontain considerable hemoglobin,
a wide variation in the morphological characteristics of the
cells is observed. In the field shown here, larger cells with a
relatively low degree of condensation of chromatin are present
in significant numbers. Only one or two cells exhibit a pheno-
type in which hemoglobin staining is most intense and chro-
matin is highly condensed. Examination of many fields from
cultures similar to the one shown here reveals that, although
TABLE I
Stability of Cells Prelabeled with
￿
CJThymidine Grown
under Various Culture Conditions
Cells were labeled for 6h with O.SyCi/ml [methyl-'"C]thymidine (Amersham
Corp., 55 mCi/mmol), then concentrated by centrifugation, washed, and
resuspended in fresh medium, and divided into three subcultures. One
culture was treated with 1.8% DMSO, a second culture was treated with 1.8%
DMSO in medium supplemented with 4% BSAand 2 x10-3 M Fe in the form
of iron-dextran complex, while a third culture was resuspended in medium
alone. At each time indicated in the table, an equal aliquot of the culture was
harvested by centrifugation, nuclei were isolated, lysed, sonicated, and
['"C]thymidine remaining in acid-precipitable form was determined, as de-
scribed in Materials and Methods.
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Time of induc-
tion
h
%
DMSO
of acid precipitable'"C
DMSO and
BSA Uninduced
0 100 100 100
12 97 97 99
24 98 96 99
36 95 96 98
48 95 98 97
60 93 94 99
72 90 97 95
84 78 95 98
96 67 97 96
108 37 91 97
120 35 95 98
144 29 93 96FIGURE 1
￿
Morphology of terminally differentiated MEL cells . Cells, clones PC4(F) or PC4-7(A-E ), were treated for 6 d with 1 .8%
DMSO in a- medium with 13% FCS and 5 x 10-3 M iron-déxtran, supplemented with : A, no addition ; 8, 2.5% Ficoll-400 ; C, 5%
BSA; D, 3% BSA; E, 3% BSA ; and F, 5% BSA . Each photograph is of a cytocentrifuge preparation of cells stained with benzidine and
counter-stained with hematoxylin as described (13) .
the proportions of different morphological phenotypes vary
from culture to culture, a similar heterogeneous distribution in
the morphology of the cells is characteristic of such cultures .
By contrast, cells derived from cultures to which Ficoll orBSA
has been added exhibit a much more uniform morphology . In
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Fig . 1 B, afield of cells from aculture treated with DMSO and
2.5% Ficoll for 6d is shown . Allof the cells in this field exhibit
nuclei with highly condensedchromatin or are actually enucle-
ated . All show intense benzidine staining . Treatment with
DMSO and 5% BSA (Fig . 1 C) gives rise to cultures in whichmost of the cells contain high levels of hemoglobin and are
enucleated, whereas treatment with 3% BSA (Fig. 1 D and E)
gives rise to cultures in which almost all cells have high
hemoglobin levels but retain their nuclei. The nuclei exhibit
the highly condensed chromatin typical of normal orthochro-
matophilic erythroblasts at the stagejust before enucleation.
A technical problem which must be monitored with extreme
care to achieve uniform cultures of terminally differentiating
cells in this system is overgrowth by apopulation ofcells which
do not respond to inducer. In general, we found that the most
effective means to circumvent this problem is to use a freshly
cloned population of cellswhich exhibit a very high proportion
of committed cells upon exposure to inducer. To facilitate
experimental manipulations, we freeze multiple aliquots of
such a population underconditions where a high proportion of
cells (>70%) recover from freezing (as described in Materials
and Methods) andperformexperiments within a few days after
such recovery. If, however, a population ofcells in which even
a relatively small number of cells are refractory to the effects
of inducer is used, results similar to those shown in Fig. 1 F
may be obtained. In this field we observe two morphological
phenotypes despite the fact that the medium has been supple-
mented with 5% BSA. Against a background of cells with an
appearance similar to that of the cells shown in Fig. 1 C (with
considerable hemoglobin and enucleated) we observe a group
of larger cells with uncondensed chromatin. Since the enucle-
ated cells no longer have proliferative capacity while the less
mature cells are clearly multiplying, it is apparent that in such
a culture the less differentiated cells will overgrow the termi-
nally differentiated population. For the production ofuniform
populations of end-stage cells to study the biochemistry of the
terminal differentiation process, such a situation is clearly
undesirable. As discussed above, the use of a freshly cloned,
highly responsive cell population in our hands eliminates this
possibility.
Analysis of the cell volume distribution of these cultures in
comparison to a culture treated with DMSO alone is shown in
Fig. 2. It is clear that the modal cell volume (MCV) of the
BSA-treated culture is _100 FIm
3-similar to the MCV of
normal mouse reticulocytes. The volume distribution is quite
narrow, indicating a relatively uniform cell population. By
contrast, a cell population treated with DMSO alone has an
MCV of -500 tLm'. The volume distribution of this cell popu-
ó
E
z
FIGURE 2 Cell volume distribution of MEL cells under different
culture conditions. Cell volume was determined in three different
cultures. Exponentially growing MEL cells in a- medium. ( . - " ).
Cell treated with 1.8% DMSO for 4.5 days in a medium (--). Cells
treated with 1.5% DMSO for 5.5 d in a medium supplemented with
4% BSA and 2 X 10-3 M iron-dextran (-). Cell volume was
determined using an automaticcell counter (Coulter counter Model
ZBI) equipped with pulse height channelyzer.
lation is much broader than that of the BSA-treated culture,
indicative of heterogeneity in this population.
The physical stabilization of MEL cells may be due to a
specific factor present in our preparation of BSA or to a more
general property of BSA. To distinguish these alternatives we
performed a series of experiments in which Ficoll has been
substituted for BSA. This series of experiments (Fig. 1 B; and
V. Volloch and D. Housman, unpublished observations) indi-
cate that Ficoll is an effective substitute for BSA in physical
stabilization of MELcells.
Ourobservations on cell morphology and volume suggested
to us that addition of the BSA or Ficoll to the culture medium
had the effect of preserving the physical integrity of differen-
tiated MEL cells. An issue of great significance in the use of
MEL cells as an an vitro model for erythroid differentiation is
the biochemical characteristics of the differentiated cell popu-
lation. In most previous reports in which the levels of globin
synthesis or globin mRNA have been determined in DMSO-
treated MEL cells, these levels have not reached the level of
reticulocytes. The levels obtained by us forthese parameters in
MEL cells treated with DMSO alone are shown in Fig. 3. The
values we obtain are quite typical of those reported previously
andare at leastfour to five timeslowerthan thevalues obtained
for these same parameters in authentic mouse reticulocytes.
For example, hybridization with globin cDNA of total cyto-
plasmic RNA from 745-PC-4 cells treated with DMSO alone
gives a half Rot value of 1.5. Cytoplasmic RNA isolated from
mouse reticulocytes gives a half Rot value of -1.5 X 10-',
indicative of a content of globin mRNA tenfold higher than
that of the DMSO-treated MEL cells. Cytoplasmic RNA iso-
lated from MEL cells treated with DMSO and BSA gives a
halfRot value of0.95 X 10-' when hybridized to globin cDNA.
This result indicates that theglobin mRNA level in these cells
is almost equal to thevalueobserved in reticulocytes. Asimilar
relationship in the globin mRNA content of poly(A) + RNA
is observed when MEL cells treated with DMSO alone are
FIGURE 3
￿
Analysis of globin mRNA levels by hybridization to glo-
bin cDNA. MEL cells were treated with 1 .8% DMSO for 96 h in a
medium, +13% FCS for 150 h in the same medium supplemented
with 5% BSAand 2 x 10-3 M Fe in the form of iron-dextran complex.
Cytoplasmic RNA from these cells was purified as described in
Materials and Methods. A sample of this RNA was subjected to
oligo(dT) cellulose affinity chromatography. The hybridization re-
action with [3 -Jglobin cDNA (1,000 cpm, 2.4 X 107 cpm/tLg) was
carried out as described in Materials and Methods, and the per-
centage of the radioactive globin cDNA hybridized wasdetermined
by sensitivity to S1 nuclease as described in Materials and Methods.
Mousereticulocyte total cell RNA (O). Mouse reticulocyte poly(A)+
RNA ("). Cytoplasmic RNA from MEL cells treated with DMSO in
medium supplemented with BSA (0). Cytoplasmic poly(A)+ RNA
from MEL cells treated with DMSO in medium supplemented with
BSA ("). Cytoplasmic RNA from MEL cells treated with DMSO in
regular medium (A). Cytoplasmic poly(A)+ RNA from MEL cells
treated with DMSO in regular medium (A).
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DMSO and BSA. HalfRut values of 3 x 10-1, 8 x 10-3, and 6
x 10-3 are observed when poly(A) + RNA from these cell
populations are hybridized to globin cDNA. Treatment of
MEL cells with DMSO in the presence of 3% BSA leads to a
level of globin synthesis of -85% of total cellular protein
synthesis, a value comparable to the level of -90% of cellular
protein synthesis observed in reticulocytes. Similarly, globin
mRNA levels in MEL cells treated with DMSO + BSA reach
a proportion of 1.5-2% of cellular RNA. This value is compa-
rable to the value observed for reticulocyte RNA. By contrast,
globin mRNA represents only 0.2-0.3% of the total cellular
RNA in cells treated with DMSO alone. These results are
again consistent with the view that addition of BSA to the
medium physically stabilizes terminally differentiated MEL
cells.
The experiments on levels ofglobin mRNA were performed
on cellstreated with DMSO or with DMSO + BSAat times at
which maximum values for these parameters are observed
under each growth condition. Subsequent to 4 d of exposure to
DMSO, lysis of differentiated cells and overgrowth of nonre-
sponding cellsactually reduce the proportion ofglobin mRNA
and the proportion of globin synthesis in these cells. By con-
trast, cultures in which end-stage cells are stabilized with BSA
continue to show increases in the proportion of globin mRNA
and globin synthesis until 6 d after the addition of inducer.
DISCUSSION
The demonstration that MEL cells induced with DMSO to
differentiate give rise to a physically unstable population of
terminally differentiated cells has a number of significant
implications. In particular, it appears essential to reevaluate
studies on the biochemical properties of DMSO-treated MEL
cells to determine whetherparticular measurements have been
influenced by the lysis of end-stage cells.
For example, it has been reported that globin mRNA is
unstable in MELcellstreated with DMSO for 4 d (12). Globin
mRNA is reported to exhibit an apparent half-life of 17 h in
such cells. It is possible, however, that the apparent instability
of globin mRNA in DMSO-treated MELcells is a reflection of
the physical instability of the cells themselves. We have ob-
tained data which support this view and in fact indicate that
globin mRNA is actually more stable than other cellular
mRNAs (17). This result would account for the high levels of
globin synthesis and globin mRNA observed in the physically
stabilized MEL cells characterized for these parameters in our
study.
The control mechanisms which govern other aspects of the
differentiated phenotype are now more amenable to study in
the MEL cell system. For example, reticulocytes are known to
exhibit a fourfold higher levelof tRNAhi .than other cell types.
Using MEL cells stabilized by the procedures described here,
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we have been able to reproduce this increase in tRNAhia levels
characteristic oferythroid differentiation (M. Litt, V. Volloch,
and D. Housman, manuscript in preparation). These results
open the possibility of the use of the MEL cell system for
analysis of the control mechanisms which are responsible for
this shift in the tRNA spectrum.
Other studies of the terminal differentiation process should
also be possible using the techniques described here. In partic-
ular, the analysis ofthedifferentiationof the specialized eryth-
rocyte cell membrane should be facilitated by the availability
ofareliable in vitro system. Similarly, studies directed towards
understanding the mechanism of chromatin condensation and
enucleation in differentiating erythroblasts should be feasible
in the MEL cell system. Finally, the coordination mechanisms
which integrate various aspects of the differentiation process
may now be more amenable to study in the MEL cell system.
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